Odenthal, Germany

Karl-Heinz Wahl

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Healthcare Aktiengesellschaft, Bayer Yakuhin, Ltd.. Active years: 1997-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl-Heinz Wahl. Retrieved from https://idiyas.com/inventor/karl-heinz-wahl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997-2006

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Karl-Heinz Wahl

Introduction: Karl-Heinz Wahl, a distinguished inventor hailing from Odenthal, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Karl-Heinz Wahl holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Karl-Heinz Wahl has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many around the world.

Collaborations: Karl-Heinz Wahl has collaborated with leading research institutions, universities, and companies to further develop and implement his innovative ideas, demonstrating his commitment to advancing technology through strategic partnerships.

Conclusion: Karl-Heinz Wahl's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his legacy as a pioneering inventor in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…